PANACEA BIOTEC PHARMA LIMITED
PANACEA BIOTEC PHARMA LIMITED having CIN U24299DL2019PLC347566 is 6 years , 3 month & 1 days old Public Indian Company incorporated on 22 Mar 2019. It is classified as Non-government company and is registered at ROC Delhi. Its authorized share capital is Rs. 600,000,000 and its paid up capital is Rs. 1,000,000. It's NIC code is 24299 (which is part of its CIN).
As per the NIC code, it is involved in Manufacture Of Fine Chemicals And Other Chemical Products N.E.C. (Including Anti-Knock Preparations . PANACEA BIOTEC PHARMA LIMITED Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-30-2023. Directors of PANACEA BIOTEC PHARMA LIMITED are Narotam Kumar Juneja and Rajesh Jain.
PANACEA BIOTEC PHARMA LIMITED ' Corporate Identification Number (CIN) is U24299DL2019PLC347566 and its registration number is 347566. Users may contact PANACEA BIOTEC PHARMA LIMITED on its Email address - pharma@panaceabiotec.com Registered address of PANACEA BIOTEC PHARMA LIMITED is B-1 Extension/A-27, Mohan Co-operative Industrial Estate, Mathura Road,NEW DELHI,Delhi,India-110044. Current status of PANACEA BIOTEC PHARMA LIMITED is - Active.
Key Indicators
as on 23/06/2025
as on 23/06/2025
Company Information
| CIN | U24299DL2019PLC347566 |
|---|---|
| Company Status | Active |
| Registration Number | 347566 |
| Date of Incorporation | 03/22/2019 |
| RoC | ROC Delhi |
| Company Age | 6 years & 95 days |
| Authorized Capital | ₹ 600000000 |
| Paid-up capital | ₹ 1000000 |
| Company Category | Company limited by shares |
| Company Sub-Category | Non-government company |
| Class of company | Public |
| Activity | Manufacture Of Fine Chemicals And Other Chemical Products N.E.C. (Including Anti-Knock Preparations |
| Listing status | Unlisted |
| Date of Last Annual General Meeting | 31-03-2023 |
| Date of Latest Balance Sheet | 31-03-2023 |
Contact
| Email ID | pharma@panaceabiotec.com |
|---|---|
| Address | B-1 Extension/A-27, Mohan Co-operative Industrial Estate, Mathura Road NEW DELHI Delhi India 110044 |
| Website | panaceabiotec.com |
| Contact Number | +91******* |
Location on Map
Director
| DIN | Name | Date OF Appointment | Designation | Tenure |
|---|---|---|---|---|
| 02982164 | 24 Mar 2023 | Director | 6 years | |
| 02104220 | 16 Feb 2023 | Director | 6 years | |
| 07137968 | 25 Apr 2023 | Director | 6 years | |
| 02618776 | 11 Dec 2020 | Director | 6 years | |
| 00013053 | 13 Jul 2023 | Director | 6 years | |
| 03556647 | 22 Mar 2019 | Director | 6 years | |
| 00013950 | 22 Mar 2019 | Director | 6 years | |
| 01204817 | 06 Mar 2023 | Director | 6 years |
Companies connected through Directors
| Name | Status | Paid Up Capital | Common Directors | Address |
|---|---|---|---|---|
| 1,16,92,68,20,600.00 | 1 | West Bengal | ||
| 20,00,00,000.00 | 2 | Maharashtra | ||
| 22,26,20,746.00 | 2 | Punjab | ||
| 11,69,43,000.00 | 2 | Telangana |
Charges on assets
Others
No. of Loans: 2
Total Amount: 16,184,448,363.00 cr
| Charge Holder | Branch | Amount | Date of creation | Modification | Satisfaction | Status |
|---|---|---|---|---|---|---|
| Others | KURLA COMPLEX BANDRA EAST | 7,544,448,363 | 01 Feb, 2020 | 16 Nov, 2021 | 03 Mar, 2022 | Closed |
| Others | KURLA COMPLEX BANDRA EAST | 8,640,000,000 | 06 Apr, 2019 | - | 01 Feb, 2020 | Closed |
Registered Details
* There is the date provided by MCA, but availability for this year is not guaranteed.
Industry
Key Metrics
** All rupee values in INR crores. Based on March 2024 numbers.
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
9.29%
0.00%
Financial Highlights
** All numbers in INR
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales |
|
|
|
|
|
| Operating profit |
|
|
|
|
|
| Net profit |
|
|
|
|
|
| Gross margin |
|
|
|
|
|
| Operating margin |
|
|
|
|
|
| Net margin |
|
|
|
|
|
| Networth |
|
|
|
|
|
| Borrowings |
|
|
|
|
|
| Assets |
|
|
|
|
|
| Debt to equity |
|
|
|
|
|
| Current ratio |
|
|
|
|
|
| ROE |
|
|
|
|
|
| Days payable |
|
|
|
|
|
| WC days |
|
|
|
|
|
Balance Sheet
**** All numbers in INR
|
Mar 2020
|
Mar 2021
|
Mar 2022
|
Mar 2023
|
Mar 2024
|
|
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| (1) Shareholders‘ funds | |
|
|
|
|
| (a) Share capita | |
|
|
|
|
| (b) Reserves and surplus | |
|
|
|
|
| (c) Money received against share warrants | |
|
|
|
|
| (2) Share application money pending allotment | |
|
|
|
|
| (3) Non-current liabilities | |
|
|
|
|
| (a) Long-term borrowings | |
|
|
|
|
| (b) Deferred tax liabilities (Net) | |
|
|
|
|
| (c) Other Long-term liabilities | |
|
|
|
|
| (d) Long-term provisions | |
|
|
|
|
| (4) Current liabilities | |
|
|
|
|
| (a) Short-term borrowings | |
|
|
|
|
| (b) Trade payables | |
|
|
|
|
| (A) total outstanding dues of micro enterprises and small enterprises; and | |
|
|
|
|
| (B) total outstanding dues of creditors other than micro enterprises and small enterprises. | |
|
|
|
|
| (c) Other current liabilities | |
|
|
|
|
| (d) Short-term provisions | |
|
|
|
|
| Total | |
|
|
|
|
| ASSETS | |||||
| Non-current assets | |
|
|
|
|
| (a) [Property, Plant and Equipment] | |
|
|
|
|
| (i) Tangible assets | |
|
|
|
|
| (ii) Intangible assets | |
|
|
|
|
| (iii)Capital work-in-progress | |
|
|
|
|
| (iv) Intangible assets under development | |
|
|
|
|
| (b) Non-current investments | |
|
|
|
|
| (c) Deferred tax assets (net) | |
|
|
|
|
| (d) Long-term loans and advances | |
|
|
|
|
| (e) Other non-current assets | |
|
|
|
|
| (2) Current assets | |
|
|
|
|
| (a) Current investments | |
|
|
|
|
| (b) Inventories | |
|
|
|
|
| (c) Trade receivables | |
|
|
|
|
| (d) Cash and cash equivalents | |
|
|
|
|
| (e) Short-term loans and advances | |
|
|
|
|
| (f) Other current assets | |
|
|
|
|
| Total assets | |
|
|
|
|
| EQUITY AND LIABILITIES | ||||
| (1) Shareholders‘ funds | ||||
| (a) Share capital | ||||
| (b) Reserves and surplus | ||||
| (c) Money received against share warrants | ||||
| (2) Share application money pending allotment | ||||
| (3) Non-current liabilities | ||||
| (a) Long-term borrowings | ||||
| (b) Deferred tax liabilities (Net) | ||||
| (c) Other Long-term liabilities | ||||
| (d) Long-term provisions | ||||
| (4) Current liabilities | ||||
| (a) Short-term borrowings | ||||
| (b) Trade payables | ||||
| (A) total outstanding dues of micro enterprises and small enterprises; and | ||||
| (B) total outstanding dues of creditors other than micro enterprises and small enterprises. | ||||
| (c) Other current liabilities | ||||
| (d) Short-term provisions | ||||
| Total | ||||
| ASSETS | ||||
| Non-current assets | ||||
| (a) [Property, Plant and Equipment] | ||||
| (i) Tangible assets | ||||
| (ii) Intangible assets | ||||
| (iii)Capital work-in-progress | ||||
| (iv) Intangible assets under development | ||||
| (b) Non-current investments | ||||
| (c) Deferred tax assets (net) | ||||
| (d) Long-term loans and advances | ||||
| (e) Other non-current assets | ||||
| (2) Current assets | ||||
| (a) Current investments | ||||
| (b) Inventories | ||||
| (c) Trade receivables | ||||
| (d) Cash and cash equivalents | ||||
| (e) Short-term loans and advances | ||||
| (f) Other current assets | ||||
| Total assets | ||||
Profit & Loss
**** All numbers in INR
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| I.Revenue from operations | |
|
|
|
|
| II. Other income | |
|
|
|
|
| III.Total Revenue (I + II) | |
|
|
|
|
| IV.Expenses | |
|
|
|
|
| (1)Cost of materials consumed | |
|
|
|
|
| (2)Purchases of Stock-in-Trade | |
|
|
|
|
| (3)Changes in inventories of finished goods work-in-progress and | |
|
|
|
|
| (4)Stock-in-Trade | |
|
|
|
|
| (5)Employee benefits expense | |
|
|
|
|
| (6)Finance costs | |
|
|
|
|
| (7)Depreciation and amortisation expense | |
|
|
|
|
| (8)Other expenses | |
|
|
|
|
| (9)Total expenses | |
|
|
|
|
| VProfit before exceptional and extraordinary items and tax (III - IV) | |
|
|
|
|
| VIExceptional items | |
|
|
|
|
| VII.Profit before extraordinary items and tax (V - VI) | |
|
|
|
|
| VIII.Extraordinary items | |
|
|
|
|
| IX.Profit before tax (VII- VIII) | |
|
|
|
|
| X. Tax expense: | |
|
|
|
|
| (1)Current tax | |
|
|
|
|
| (2)Deferred tax | |
|
|
|
|
| XI.Profit (Loss) for the period from continuing operations (VII-VIII) | |
|
|
|
|
| XII.Profit/(loss) from discontinuing operations | |
|
|
|
|
| XIII.Tax expense of discontinuing operations | |
|
|
|
|
| XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) | |
|
|
|
|
| XV.Profit (Loss) for the period (XI + XIV) | |
|
|
|
|
| XVI.Earnings per equity share: | |
|
|
|
|
| (1) Basic | |
|
|
|
|
| (2)Diluted | |
|
|
|
|
| Precentage of total incomex |
|---|
Ratio
** All numbers in INR
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt/Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Liquidity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Performance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-tax ROCE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-tax ROIC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Subsidiaries, Associate Companies & Join Ventures of Panacea Biotec Pharma Limited
| Company Identifier | Name | Percentage of Shares Held |
|---|---|---|
|
|
|
|
|
|
|
|
|
Fund Raising Activity of Panacea Biotec Pharma Limited
| Date of Allotment | Securities Alloted | Terms | Number of Securities | Nominal Amount | Premium Amount Due & Payable | Premium Amount Paid | Total Discount | Amount to be Paid on Calls (Excluding Premium) | Attachments |
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board Meetings of Panacea Biotec Pharma Limited
| Date of Filing | Date of Dispatch of Notice | Section (Companies Act 2013) | Purpose of passing the resolution | Subject Matter of Resolution | Resolution Agreed By | Special Resolution | Address |
|---|
Auditors of Panacea Biotec Pharma Limited
| Financial Year | Name of Auditor or Firm | PAN of Auditor or Firm | Membership Number | Registration Number | Address |
|---|
Outstanding Payments to Micro & Small Enterprises
| Filing Type | As On | Amount Due to MSME | Current Liabilities | Ratio to Current Liabilities | Reasons for Delay |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Complaints & Serious Complaints About Panacea Biotec Pharma Limited
Director Complain
| Date | DIN | Cessation Date | Cessation Reason | Complaint |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Serious Complaints
| Date | Complaint | Other |
|---|---|---|
|
|
|
|
|
|
|
|
|
Investor Complaints & Other Complaints
| Date | Complaint Type | Complaint Sub Type | Particulars of Secutiries | Period | Complaint | Other Details |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prosecution Details of Panacea Biotec Pharma Limited
| S.No. | Defaulting Entities | Court Name | Prosecution Section | Date of Order | Status |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FAQs- Panacea Biotec Pharma Limited
PANACEA BIOTEC PHARMA LIMITED having CIN U24299DL2019PLC347566 is 6 years , 3 month old Public Indian Company incorporated with MCA on 06 Mar 2023. PANACEA BIOTEC PHARMA LIMITED is listed in the class of Public Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Delhi with an Authorized Share Capital of 600,000,000 and paid-up capital is 1,000,000.
CIN of PANACEA BIOTEC PHARMA LIMITED is U24299DL2019PLC347566.
Address of PANACEA BIOTEC PHARMA LIMITED is B-1 extension/a-27, mohan co-operative industrial estate, mathura road,new delhi,delhi,india-110044,.
The company has 13 directors/key management personnel Avinash Kulkarni,shantanu Nalavadi,shantanu Nalavadi,manjula Upadhyay,deepak Kanvinde,rajesh Jain,ankesh Jain,sunil Anand,narotam Juneja,manjula Upadhyay,narotam Juneja,avinash Kulkarni,rajesh Jain,
Email : pharma@panaceabiotec.com
Address : B-1 Extension/A-27, Mohan Co-operative Industrial Estate, Mathura Road NEW DELHI Delhi India 110044
PANACEA BIOTEC PHARMA LIMITED is involved in activities such as Computer programming, consultancy and related activities
Popular Services
Popular Search
Top Companies in your State
- ANANGESHWAR PARWATI RAMANUGRAH PROJECTS PRIVATE LIMITED
- BEAVER TECHNOCRATE PRIVATE LIMITED
- BUSINESS LINE (ISPAT) PRIVATE LIMITED
- HARIOM ROHAN CONSTRUCTION PRIVATE LIMITED
- HIMALIYA DEVELOPERS INDIA PRIVATE LIMITED
- INDRA RANI CONSTRCTION AND SUPPLIERS PRIVATE LIMITED
- MAA SINHASINI INFRASTRUCTURE PRIVATE LIMITED
- MOTIVE BROKING & ADVISORY PRIVATE LIMITED
- NIRSHILP COMMODITIES AND TRADING PRIVATE LIMITED
- OMNIBUS INDUSTRIAL DEVELOPMENT CORPORATION OF DAMAN DIU AND DADRA NAGAR HAVELI LIMITED
- PRIMECOUNSEL PRIVATE LIMITED
- QCAP SECURITIES PRIVATE LIMITED
- SHAAFIA FOREX PRIVATE LIMITED
- SMIT (DAMAN) ESTATES PRIVATE LIMITED
- ALBEMARLE CHEMICALS PRIVATE LIMITED
- BEYOND BORDERS TRAVEL MANAGEMENT CO PRIVATE LIMITED
- COEUS EDUCATION MANAGEMENT PRIVATE LIMITED
- COFCO INTERNATIONAL INDIA PRIVATE LIMITED
- EVOTEK HYDRAULIC TECHNOLOGY INDIA PRIVATE LIMITED
- EXXONMOBIL COMPANY INDIA PRIVATE LIMITED
- HALITE PERSONAL CARE INDIA PRIVATE LIMITED
Exclusive Access 